Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Diabetes Care

• Publication date

  1981-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.4.3.366PMID 7047113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in Insulin Absorption and in Blood Glucose Control associated with Varying Insulin Injection Sites in Diabetic Patients

  1981cited by this paper
• The Effect of Aprotinin on the Absorption of Subcutaneously Injected Regular Insulin in Normal Subjects

  1980cited by this paper
• Insulin Recoverable from Tissues

  1980cited by this paper
• Seasonal cystitis.

  1980cited by this paper
• Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.

  1980cited by this paper
• A Portable System for Continuous Intravenous Insulin Delivery: Characteristics and Results in Diabetic Patients

  1980cited by this paper
• Accelerated Insulin Degradation: An Alternate Mechanism for Insulin Resistance

  1979cited by this paper
• The Intravenous, Intraperitoneal, and Subcutaneous Routes of Insulin Delivery in Diabetic Man

  1979cited by this paper
• Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.

  1979cited by this paper
• Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin

  1979cited by this paper
• Absorption of Protamine-lnsulin in Diabetic Patients - I. Preparation and Characterization of Protamine-125I-InsuIin

  1979cited by this paper
• Plasma Insulin and C-Peptide Levels During Continuous Subcutaneous Insulin Infusion

  1979cited by this paper
• complications of Diabetes Mellitus: Relationship to Metabolic Dysfunction

  1979cited by this paper
• Equilibrium Binding Assay and Kinetic Characterization of Insulin Antibodies

  1978cited by this paper
• Effects of leg exercise on insulin absorption in diabetic patients.

  1978cited by this paper
• Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone.

  1978cited by this paper
• Dietary and anticholinergic effects on intravenous glucose tolerance and insulin secretion.

  1978cited by this paper
• DEFECTIVE ABSORPTION OF INJECTED INSULIN

  1978cited by this paper
• Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.

  1978cited by this paper
• Diurnal glucose variability and hormonal regulation.

  1977cited by this paper
• THE ABSORPTION OF INSULIN

  1977cited by this paper
• Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.

  1976cited by this paper
• The immunogenicity of insulin preparations.

  1976cited by this paper
• Prolonged Suppression of Insulin Release by Insulin-Induced Hypoglycemia: Demonstration by C-Peptide Assay

  1975cited by this paper
• Serum insulin levels following administration of exogenous insulin.

  1973cited by this paper
• A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

  1973cited by this paper
• A Comparison of Acid Regular and Neutral Regular Insulin: Responses of Normal Fasted Subjects to Varying Doses of Regular Insulin

  1973cited by this paper
• Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.

  1972cited by this paper
• Effect of exercise on peripheral uptake of I-iodo insulin and glucose in nondiabetics.

  1972cited by this paper
• Immunogenicity of Insulin

  1972cited by this paper
• Variability of NPH insulin preparations.

  1971cited by this paper
• Serum-insulin levels in patients on insulin.

  1971cited by this paper
• Absorption of 131-I labeled modified insulin

  1967cited by this paper
• A receptor mechanism for the inhibition of insulin release by epinephrine in man.

  1967cited by this paper
• THE ROUTE OF INSULIN ADMINISTRATION IN THE MANAGEMENT OF DIABETES MELLITUS.

  1964cited by this paper
• Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection.

  1959cited by this paper

• DIETS: Diabetic Insulin Management System in Everyday Life

  2024influential citation
• The hidden obstacles to intranasal insulin delivery: A narrative review

  2023cites this paper
• EFFICACY AND SAFETY OF SUBCUTANEOUS INSULIN COMPARED TO INTRAVENOUS INSULIN IN THE TREATMENT OF PATIENTS WITH DIABETIC KETOACIDOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

  2023cites this paper
• Optimization of pig models for translation of subcutaneous pharmacokinetics of therapeutic proteins: Liraglutide, insulin aspart and insulin detemir.

  2021cites this paper
• Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes

  2021cites this paper
• Driver versus navigator causation in biology: the case of insulin and fasting glucose

  2020cites this paper
• Case-base maintenance of a personalised and adaptive CBR bolus insulin recommender system for type 1 diabetes

  2019cites this paper
• USE OF INHALED INSULIN IN A PATIENT WITH SUBCUTANEOUS INSULIN RESISTANCE SYNDROME: A RARE CONDITION.

  2019cites this paper
• Optimisation of the Investigation of Antibody-Mediated Dysglycaemia

  2019cites this paper
• Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet‐induced obesity

  2019cites this paper
• Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability

  2018cites this paper
• Subcutaneous Administration of Insulin is Associated With Regional Differences in Injection Depot Variability and Kinetics in The Rat.

  2018cites this paper
• Understanding concentrated insulins: a systematic review of randomized controlled trials

  2018cites this paper
• Controversies in Management of Hyperkalemia.

  2018cites this paper
• Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes.

  2017cites this paper
• Rational Design of Glucose‐Responsive Insulin Using Pharmacokinetic Modeling

  2017cites this paper
• Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?

  2017cites this paper
• Indian Injection Technique Study: Population Characteristics and Injection Practices

  2017cites this paper
• The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

  2016cites this paper
• A primer on concentrated insulins: what an internist should know

  2016cites this paper
• Treatment of hyperkalemia: something old, something new.

  2016cites this paper
• Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment

  2015cites this paper
• Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

  2015cites this paper
• Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes

  2015cites this paper
• Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin.

  2014cites this paper
• Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin

  2014cites this paper
• The RapidMist™ System for Buccal Delivery of Insulin

  2014cites this paper
• A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance

  2014cites this paper
• RandomizedCrossover Study to Examine the Necessity of an Injection-to-Meal Interval inPatientsWithType2Diabetes Mellitus and Human Insulin

  2013cites this paper
• Comparison of the pharmacokinetics of three concentrations of insulin aspart during continuous subcutaneous insulin infusion (CSII) in a pig model

  2013cites this paper
• The use of U‐500 regular insulin in the management of patients with obesity and insulin resistance

  2013cites this paper
• Modeling and Prediction in Diabetes Physiology

  2013cites this paper
• Variability of glucose‐lowering effect as a limiting factor in optimizing basal insulin therapy: a review

  2013cites this paper
• Insulin therapy: Side effects and their management

  2013cites this paper
• Empirical Approaches to the Application of Mathematical Techniques in Health Technologies

  2013cites this paper
• Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes and Human Insulin

  2013cites this paper
• Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion

  2012cites this paper
• Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin.

  2012cites this paper
• Recent Advances in the Development of an Inhaled Insulin Product

  2012cites this paper
• Clinical Use of U-500 Regular Insulin: Review and Meta-Analysis

  2012cites this paper
• Bioavailability and variability of biphasic insulin mixtures.

  2012cites this paper
• Visualization of subcutaneous insulin injections by x-ray computed tomography

  2012cites this paper
• Inhaled Human Insulin (Exubera®)

  2012cites this paper
• Untersuchungen zur adipogenen Wirkung von Insulin Detemir auf 3T3-L1-Präadipozyten

  2012cites this paper
• Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region

  2012cites this paper
• Management of Insulin-Dependent Diabetes Mellitus

  2012cites this paper
• Type 2 Diabetes: Uses of thiazolidinediones and insulin

  2011cites this paper
• A randomized clinical trial comparing granulocyte–colony‐stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation

  2011influential citation
• Prevalence of injection–meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes

  2011cites this paper
• Type 2 Diabetes

  2011cites this paper
• Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

  2011cites this paper
• Review of clinical trials: update on oral insulin spray formulation

  2010cites this paper
• Clinical efficacy and patient satisfaction with U-500 insulin use.

  2010cites this paper
• Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.

  2010cites this paper
• Use of concentrated insulin human regular (U-500) for patients with diabetes.

  2010influential citation
• Therapy of Type 1 Diabetes Mellitus

  2010cites this paper
• The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.

  2009cites this paper
• High-dose insulin therapy: is it time for U-500 insulin?

  2009cites this paper
• Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.

  2009cites this paper
• Sources of Glycemic Variability—What Type of Technology is Needed?

  2009cites this paper
• Various non-injectable delivery systems for the treatment of diabetes mellitus.

  2009cites this paper
• Clinical outcome of using insulin at 40 IU/ml and 100 IU/ml in pump treatment. Results of a controlled multi-center trial.

  2009cites this paper
• Design of Insulin Variants for Improved Treatment of Diabetes

  2009cites this paper
• Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.

  2009cites this paper
• Diabetes mellitus: Besonderheiten der Insulintherapie im Alter

  2008cites this paper
• Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes

  2008cites this paper
• A Subcutaneous Insulin Pharmacokinetic Model for Computer Simulation in a Diabetes Decision Support Role: Model Structure and Parameter Identification

  2008cites this paper
• Variability of Insulin Action : Does It Matter ?

  2008cites this paper
• New Insulin Analogues and Routes of Delivery

  2008cites this paper
• Variability of Insulin Action: Does It Matter?

  2008cites this paper
• A Subcutaneous Insulin Pharmacokinetic Model for Computer Simulation in a Diabetes Decision Support Role: Validation and Simulation

  2008cites this paper
• Model-Based Therapeutics for Type 1 Diabetes Mellitus

  2008cites this paper
• Variability of Insulin Action and Clinical Effects

  2007cites this paper
• Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin

  2007cites this paper
• Insulin Therapy in Adults with Type 1 Diabetes Mellitus

  2007cites this paper
• Inhaled insulin and the lung.

  2007cites this paper
• Insulin aspart: a review

  2006cites this paper
• Insulin detemir: from concept to clinical experience

  2006cites this paper
• Initiating Insulin Therapy in Patients with Type 2 Diabetes: A Practical Approach

  2006cites this paper
• Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir

  2006cites this paper
• Variability in Insulin Action: Mechanisms, Implications, and Recent Advances

  2006cites this paper
• Numerical approximation of mathematical model for absorption of subcutaneously injected insulin

  2006cites this paper
• Is Weight Gain an Unavoidable Consequence of Insulin Therapy

  2006cites this paper
• Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus.

  2006cites this paper
• Noninjectable methods of insulin administration.

  2006cites this paper
• Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.

  2006cites this paper
• Using Glucose Tolerance Tests to Model Insulin Secretion and Clearance

  2005cites this paper
• Inhaled insulin

  2005cites this paper
• Subcutaneous insulin: pharmacokinetic variability and glycemic variability.

  2005cites this paper
• Reproducibility and variability in the action of injected insulin.

  2005influential citation
• Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double‐blinded crossover study

  2005cites this paper
• Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management

  2005cites this paper
• Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.

  2004cites this paper
• Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

  2004cites this paper
• Study of porcine and human isophane (NPH) insulins in normal subjects

  2004cites this paper
• Clinical pharmacological aspects of growth hormone administration.

  2004cites this paper
• Are our insulins more or less predictable than our patients

  2004cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin

  2004cites this paper
• Subcutaneous insulin resistance, learning disabilities and unstable diabetes

  2004cites this paper
• Insulin detemir: improving the predictability of glycaemic control

  2004cites this paper